Published in Invest Ophthalmol Vis Sci on October 01, 1997
Bimatoprost, prostamide activity, and conventional drainage. Invest Ophthalmol Vis Sci (2007) 1.05
Enhancement of scleral macromolecular permeability with prostaglandins. Trans Am Ophthalmol Soc (2001) 0.94
Travoprost in the management of open-angle glaucoma and ocular hypertension. Clin Ophthalmol (2007) 0.87
Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost. Br J Ophthalmol (2003) 0.86
Latanoprost Stimulates Ocular Lymphatic Drainage: An In Vivo Nanotracer Study. Transl Vis Sci Technol (2013) 0.86
Latanoprost in port wine stain related paediatric glaucoma. Br J Ophthalmol (2003) 0.82
Effects of prostaglandin analogues on aqueous humor outflow pathways. J Ocul Pharmacol Ther (2013) 0.81
Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension. Br J Ophthalmol (2006) 0.80
Combining corneal hysteresis with central corneal thickness and intraocular pressure for glaucoma risk assessment. Eye (Lond) (2012) 0.79
Role of PKCepsilon in PGF2alpha-stimulated MMP-2 secretion from human ciliary muscle cells. J Ocul Pharmacol Ther (2008) 0.78
Evaluation of the Effect of Latanoprostene Bunod Ophthalmic Solution, 0.024% in Lowering Intraocular Pressure over 24 h in Healthy Japanese Subjects. Adv Ther (2015) 0.77
Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study. Adv Ther (2016) 0.76
Novel Pharmacologic Candidates for Treatment of Primary Open-Angle Glaucoma. Yale J Biol Med (2017) 0.75
Prostaglandin-associated periorbitopathy in latanoprost users. Clin Ophthalmol (2014) 0.75
Topical latanoprost causes posterior movement of lens in a patient with exfoliation syndrome and subluxated lens: a case report. J Med Case Rep (2007) 0.75
The additive effects on intraocular pressure of combining nipradilol 0.25% and latanoprost 0.005% ophthalmic solutions: a prospective, randomized, multicenter study. Jpn J Ophthalmol (2008) 0.75
Evaluating intraocular pressure-lowering solutions for the treatment of open-angle glaucoma: comparison between bimatoprost 0.03% and bimatoprost 0.01% - an observational switch study. Clin Ophthalmol (2017) 0.75
Reproducibility of nerve fiber layer thickness measurements by use of optical coherence tomography. Ophthalmology (2000) 3.34
Polyamines: mysterious modulators of cellular functions. Biochem Biophys Res Commun (2000) 3.33
Discriminating between normal and glaucomatous eyes using the Heidelberg Retina Tomograph, GDx Nerve Fiber Analyzer, and Optical Coherence Tomograph. Arch Ophthalmol (2001) 2.99
Simultaneous indocyanine green and fluorescein angiography using a confocal scanning laser ophthalmoscope. Arch Ophthalmol (1998) 2.96
Detecting early glaucoma by assessment of retinal nerve fiber layer thickness and visual function. Invest Ophthalmol Vis Sci (2001) 2.54
Reproducibility of topographic measurements of the normal and glaucomatous optic nerve head with the laser tomographic scanner. Am J Ophthalmol (1991) 2.48
The retinal nerve fiber layer thickness in ocular hypertensive, normal, and glaucomatous eyes with optical coherence tomography. Arch Ophthalmol (2000) 2.33
Agreement between spectral-domain and time-domain OCT for measuring RNFL thickness. Br J Ophthalmol (2009) 2.12
Complications of glaucoma surgery. Ocular decompression retinopathy. Arch Ophthalmol (1992) 2.06
Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest Ophthalmol Vis Sci (1997) 2.04
Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma. Invest Ophthalmol Vis Sci (2000) 1.97
Polyamine transport in bacteria and yeast. Biochem J (1999) 1.89
Interpretation of automated perimetry for glaucoma by neural network. Invest Ophthalmol Vis Sci (1994) 1.86
Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science (1999) 1.85
Mechanisms of optic nerve damage in primary open angle glaucoma. Surv Ophthalmol (1994) 1.81
Twenty-four-hour pattern of intraocular pressure in the aging population. Invest Ophthalmol Vis Sci (1999) 1.80
Malignant transformation by overproduction of translation initiation factor eIF4G. Cancer Res (1997) 1.70
Secretion of interferon by Bacillus subtilis. Gene (1983) 1.70
Atrophy of relay neurons in magno- and parvocellular layers in the lateral geniculate nucleus in experimental glaucoma. Invest Ophthalmol Vis Sci (2001) 1.68
Severe vision loss and neovascular glaucoma complicating superior ophthalmic vein approach to carotid-cavernous sinus fistula. Am J Ophthalmol (1997) 1.67
Spatially resolved birefringence of the retinal nerve fiber layer assessed with a retinal laser ellipsometer. Appl Opt (1992) 1.66
Short-wavelength automated perimetry and motion automated perimetry in patients with glaucoma. Arch Ophthalmol (1997) 1.65
Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma. Arch Ophthalmol (2000) 1.62
Formation of a compensatory polyamine by Escherichia coli polyamine-requiring mutants during growth in the absence of polyamines. J Bacteriol (1986) 1.62
Detection of early glaucomatous structural damage with confocal scanning laser tomography. J Glaucoma (1998) 1.56
Characteristics of the gene for a spermidine and putrescine transport system that maps at 15 min on the Escherichia coli chromosome. J Biol Chem (1991) 1.50
RIKEN integrated sequence analysis (RISA) system--384-format sequencing pipeline with 384 multicapillary sequencer. Genome Res (2000) 1.50
A regulatory domain (R1-R2) in the amino terminus of the N-methyl-D-aspartate receptor: effects of spermine, protons, and ifenprodil, and structural similarity to bacterial leucine/isoleucine/valine binding protein. Mol Pharmacol (1999) 1.49
Characteristics of the operon for a putrescine transport system that maps at 19 minutes on the Escherichia coli chromosome. J Biol Chem (1993) 1.49
The definition of normal-tension glaucoma. J Glaucoma (1998) 1.47
Antizyme protects against abnormal accumulation and toxicity of polyamines in ornithine decarboxylase-overproducing cells. Proc Natl Acad Sci U S A (1994) 1.46
Reproducibility of retardation measurements with the nerve fiber analyzer II. J Glaucoma (1997) 1.45
Liposome suppression of proliferative vitreoretinopathy. Rabbit model using antimetabolite encapsulated liposomes. Invest Ophthalmol Vis Sci (1991) 1.44
Human trabecular cells. I. Establishment in tissue culture and growth characteristics. Invest Ophthalmol Vis Sci (1979) 1.43
A comparison of optical coherence tomography and retinal nerve fiber layer photography for detection of nerve fiber layer damage in glaucoma. Ophthalmology (2000) 1.43
Anterior chamber angle imaging with optical coherence tomography. Eye (Lond) (2011) 1.43
Nocturnal elevation of intraocular pressure in young adults. Invest Ophthalmol Vis Sci (1998) 1.42
Lateral geniculate nucleus in glaucoma. Am J Ophthalmol (1994) 1.40
Agreement between clinicians and a confocal scanning laser ophthalmoscope in estimating cup/disk ratios. Am J Ophthalmol (1995) 1.39
Assessment of rates of structural change in glaucoma using imaging technologies. Eye (Lond) (2011) 1.39
Reducing corneal toxicity of 5-fluorouracil in the early postoperative period following glaucoma filtering surgery. Aust N Z J Ophthalmol (1991) 1.39
Using optical imaging summary data to detect glaucoma. Ophthalmology (2001) 1.37
Confocal scanning infrared laser ophthalmoscopy for indocyanine green angiography. Am J Ophthalmol (1995) 1.35
The relationship between structural and functional alterations in glaucoma: a review. Semin Ophthalmol (2000) 1.35
Ethnic differences in optic nerve head topography. J Glaucoma (1995) 1.33
Immediate intraocular pressure response to argon laser trabeculoplasty. Am J Ophthalmol (1983) 1.29
Interobserver variability of optic disk variables measured by confocal scanning laser tomography. Am J Ophthalmol (2001) 1.28
Distinct effects of fatty acids on translocation of gamma- and epsilon-subspecies of protein kinase C. J Cell Biol (1998) 1.27
Optic nerve head topography in ocular hypertensive eyes using confocal scanning laser ophthalmoscopy. Am J Ophthalmol (1996) 1.26
Properties and structure of spermidine acetyltransferase in Escherichia coli. J Biol Chem (1994) 1.24
Multiple polyamine transport systems on the vacuolar membrane in yeast. Biochem J (2001) 1.24
Effect of inverted body position on intraocular pressure. Am J Ophthalmol (1984) 1.22
A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics. Cell Death Dis (2011) 1.21
Crystal structure of PotD, the primary receptor of the polyamine transport system in Escherichia coli. J Biol Chem (1996) 1.21
Nerve fiber layer measurements with scanning laser polarimetry in ocular hypertension. Arch Ophthalmol (1997) 1.20
Interaction between polyamines and nucleic acids or phospholipids. Arch Biochem Biophys (1982) 1.20
Relationship of optic disc topography to optic nerve fiber number in glaucoma. Arch Ophthalmol (1998) 1.19
Decrease in cell viability due to the accumulation of spermidine in spermidine acetyltransferase-deficient mutant of Escherichia coli. J Biol Chem (1995) 1.18
Influence of the number of laser burns administered on the early results of argon laser trabeculoplasty. Am J Ophthalmol (1983) 1.18
Correlation between the inhibition of cell growth by accumulated polyamines and the decrease of magnesium and ATP. Eur J Biochem (1993) 1.18
Optic neuropathy associated with cryptococcal arachnoiditis in AIDS patients. Am J Ophthalmol (1989) 1.17
Limbal anesthesia for cataract surgery. Ophthalmic Surg (1990) 1.16
Estimation of polyamine distribution and polyamine stimulation of protein synthesis in Escherichia coli. Arch Biochem Biophys (1993) 1.16
Identification of a gene for a polyamine transport protein in yeast. J Biol Chem (1999) 1.15
Apparently unidirectional polyamine transport by proton motive force in polyamine-deficient Escherichia coli. J Bacteriol (1986) 1.15
Effect of cataract and pupil size on image quality with confocal scanning laser ophthalmoscopy. Arch Ophthalmol (1997) 1.15
Change in optic disk topography after trabeculectomy. Am J Ophthalmol (1996) 1.14
Intraocular and episcleral venous pressure increase during inverted posture. Am J Ophthalmol (1987) 1.14
Papain inhibitions by optically active E-64 analogs. J Biochem (1981) 1.14
Comparisons of anterior segment biometry between Chinese and Caucasians using anterior segment optical coherence tomography. Br J Ophthalmol (2010) 1.13
Adjusting the dose of 5-fluorouracil after filtration surgery to minimize side effects. Ophthalmology (1987) 1.13
Topical prostaglandin F2alpha treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway. Arch Ophthalmol (1999) 1.13
Matrix metalloproteinases in human diabetic and nondiabetic vitreous. Retina (2001) 1.12
Activation of N-methyl-D-aspartate receptors by glycine: role of an aspartate residue in the M3-M4 loop of the NR1 subunit. Mol Pharmacol (1996) 1.12
The selectivity filter of the N-methyl-D-aspartate receptor: a tryptophan residue controls block and permeation of Mg2+. Mol Pharmacol (1998) 1.12
Optic disk topography after medical treatment to reduce intraocular pressure. Am J Ophthalmol (2000) 1.11
Cystoid macular edema associated with topical latanoprost in glaucomatous eyes with a normally functioning blood-ocular barrier. J Glaucoma (2001) 1.11
Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: implications for uveoscleral outflow. Surv Ophthalmol (1997) 1.09
Assessment of the retinal nerve fiber layer in clinical trials of glaucoma neuroprotection. Surv Ophthalmol (2001) 1.09
Short-wavelength color visual fields in glaucoma suspects at risk. Am J Ophthalmol (1993) 1.08
Characterization of non-toxic mutant toxins of Vero toxin 1 that were constructed by replacing amino acids in the A subunit. Microb Pathog (1993) 1.07
Uveitis associated with sarcoidosis and angiotensin converting enzyme. Am J Ophthalmol (1980) 1.07
Active optical depth resolution improvement of the laser tomographic scanner. Appl Opt (1989) 1.06
Decrease in the S1 protein of 30-S ribosomal subunits in polyamine-requiring mutants of Escherichia coli grown in the absence of polyamines. Eur J Biochem (1981) 1.06
Imaging of cyclodialysis cleft by ultrasound biomicroscope. Am J Ophthalmol (1994) 1.05
Betaxolol in patients with glaucoma and asthma. Am J Ophthalmol (1986) 1.05
Isolating the effects of primary open-angle glaucoma on the contrast sensitivity function. Am J Ophthalmol (1991) 1.05
The 1.8-A X-ray structure of the Escherichia coli PotD protein complexed with spermidine and the mechanism of polyamine binding. Protein Sci (1996) 1.04
Polyamine uptake systems in Escherichia coli. Res Microbiol (2001) 1.04
Color perimetry for assessment of primary open-angle glaucoma. Invest Ophthalmol Vis Sci (1990) 1.04
The mechanism of action of prostaglandins on uveoscleral outflow. Curr Opin Ophthalmol (2000) 1.03
Histomorphometric analysis of optic nerve changes in experimental glaucoma. J Glaucoma (1999) 1.03
The organization of actin filaments in human polymorphonuclear leukocytes. Anat Rec (1984) 1.03
Mapping structural to functional damage in glaucoma with standard automated perimetry and confocal scanning laser ophthalmoscopy. Am J Ophthalmol (1998) 1.02
Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells. Curr Eye Res (1996) 1.02